Cyclosporine therapy affects aminotransferase activity but not hepatitis C virus RNA levels in chronic hepatitis C

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 1, 1997, Pages 62-66

  Kakumu, Shinichi ^a   Takayanagi, Masahiro ^a   Iwata, Kazuo ^a   Okumura, Akihiko ^a   Aiyama, Toshiyuki ^a   Ishikawa, Tetsuya ^a   Nadai, Masayuki ^a   Yoshioka, Kentaro ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis C; Cyclosporin; HCV RNA; Serum aminotransferase

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA INTERFERON; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLOSPORIN A; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS; HUMAN; IMMUNOASSAY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031057465     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00348.x     Document Type: Article

References (32)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA derived from a blood borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
2. Kuo G, Choo Q-L, Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-4.
3. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-5.
4. Weiner AJ, Geysen HM, Christopherson C et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections. Proc. Natl Acad. Sci. USA 1992; 89: 3468-72.
5. Koziel MJ, Dudley D, Wong JT et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J. Immunol. 1992; 149: 3339-44.
6. Botarelli P, Brunnetto MR, Minutello MA et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993; 104: 580-7.
7. Ferrari C, Valli A, Galati L et al. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 1994; 19: 286-95.
8. Schupper H, Hayashi P, Scheffel J et al. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C. Hepatology 1993; 18: 1055-60.
9. Iwata K, Wakita T, Okumura A et al. IFN-γ production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology 1995; 22: 1057-64.
10. Davis GL, Balart LA, Schiff ER et al. Treatment of chronic hepatitis C with recombinant interferon-alfa. A multicenter randomized, controlled trial. N. Engl. J. Med. 1989; 321: 1501-6.
11. Di Bisceglie AM, Martin P, Kassianides C et al. Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double blind, placebo-controlled trial. N. Engl. J. Med. 1989; 321: 1506-10.
12. Kahan BD. Cyclosporin. N. Engl. J. Med. 1989; 321: 1725-38.
13. Ellis CN, Fradin MS, Messana JM et al. Cyclosporin for plaque-type psoriasis. Results of a multidose, double-blind trial. N. Engl. J. Med. 1991; 324: 277-84.
14. Dougados M. Cyclosporin in rheumatoid arthritis. Clin. Exp. Rheumatol, 1994; 12 (Suppl. 11): S75-8.
15. Sherman KE, Narkewicz M, Pinto PC. Cyclosporine in the management of corticosteroid-resistant type 1 autoimmune chronic active hepatitis. J. Hepatol. 1994; 21: 1040-7.
16. Cattran DC, Greenwood C, Ritchie S et al. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int. 1995; 47: 1130-5.
17. Reem GH, Cook LA, Vilcek J. Gamma Interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. Science 1983; 221: 63-5.
18. Elliott JF, Lin Y, Mizel SB, Bleackley RC, Harnish DG, Paetkau V. Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science 1984; 226: 1439-41.
19. Magrin S, Craxi A, Fabiano C et al. Hepatitis C viremia in chronic liver disease: relationship to interferon-γ or corticosteroid treatment. Hepatology 1994; 19: 273-9.
20. Fong TL, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG. Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994; 107: 196-9.
21. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
22. Yoshioka K, Kakumu S, Wakita T et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-γ therapy: Relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-9.
23. Yatscoff RW, Copeland KR, Faracl CJ, Abbott TDX. Monoclonal antibody assay evaluated for measuring cyclosporine in whole blood. Clin. Chem. 1990; 36: 1969-73.
24. Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J. Gen. Virol. 1992; 73: 673-9.
25. Simmonds P, Holmes EC, Cha TA et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J. Gen. Virol. 1993; 74: 2391-9.
26. Rakela J, Redeker AG, Weliky B. Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis. Gastroenterology 1983; 84: 956-60.
27. Yee GC, Self SG, McGuire TR, Carlin J, Sanders JE, Deeg HJ. Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic bone marrow transplantation. N. Engl. J. Med. 1988; 319: 65-70.
28. Kahan BD. Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation 1985; 40: 457-76.
29. Zachariae H, Olsen TS. Efficacy of cyclosporin A (CyA) in psoriasis: An overview of dose/response, indications, contraindications and side-effects. Clin. Nephrol. 1995; 43: 154-8.
30. Pickrell MD, Sawers R, Michael J. Pregnancy after renal transplantation: severe intrauterine growth retardation during treatment with cyclosporin A. BMJ 1988; 296: 825.
31. Burdmann EA, Andoh TF, Rosen S et al. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A. Kidney Int. 1994; 45: 684-91.
32. Gretch D, Corey L, Wilson J et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: High-titer viremia correlates with advanced stage of disease. J. Infect. Dis. 1994; 169: 1219-25.